Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
We show that high doses of salicylates reverse hyperglycemia, hyperinsulinemia, and dyslipidemia in obese rodents by sensitizing insulin signaling. Activation or overexpression of the IκB kinase β (IKKβ) attenuated insulin signaling in cultured cells, whereas IKKβ inhibition reversed insulin resistance. Thus, IKKβ, rather than the cyclooxygenases, appears to be the relevant molecular target. Heterozygous deletion ( Ikkβ +/− ) protected against the development of insulin resistance during high-fat feeding and in obese Lep ob/ob mice. These findings implicate an inflammatory process in the pathogenesis of insulin resistance in obesity and type 2 diabetes mellitus and identify the IKKβ pathway as a target for insulin sensitization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, inhibition or inactivation of JNK (18,26) or IKK (22,24,25,27) improves insulin sensitivity in various models of insulin resistance in association with reduced inhibitory serine phosphorylation of IRS-1 (18).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
In the citing paper
“Along these lines, numerous insulin-resistant states (e.g., obesity, type 2 diabetes, and lipid/heparin infusion) are associated with increased activation of JNK (18,21) and/or IKK (21)(22)(23)(24)(25) in parallel with inhibitory serine phosphorylation of IRS-1 (18,21).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
In the citing paper
“Accordingly, KO or inhibition of JNK1 or IKKβ prevents insulin resistance in cell and mouse models (18,22,24,25,87) as well as human models (27) of insulin resistance.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
In the citing paper
“JNK (18,21) and IKK (22,25) signaling are upregulated and activated in insulin-resistant human and rodent skeletal muscle.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., & Karin, M. (1997) · Nature · doi:10.1038/41493 · Cited by 2,125
Self-citationZandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., & Karin, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80406-7 · Cited by 1,812
Self-citationInhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,041
Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene
Li, Q., Antwerp, D. V., Mercurio, F., Lee, K.-F., & Verma, I. M. (1999) · Science · doi:10.1126/science.284.5412.321 · Cited by 963
The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling
Karin, M., & Delhase, M. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0210 · Cited by 955
Self-citation
Research works printed but not linked: 2
- Ebstein W., Berl. Klin. Wochnschr. 13, 337 (1876).
- Supplementary Web material is available on Science Online at www.sciencemag.org/cgi/content/full/293/5535/1673/DC1.
Cited by
Items 301–400 of 999
Fructose and the Metabolic Syndrome: Pathophysiology and Molecular Mechanisms
Rutledge, A. C., & Adeli, K. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00322.x · Cited by 240
“resistance, which is supported by the finding that targeted gene disruption of IKK improves insulin sensitivity.(50)”
Balasubramanyam, M., Aravind, S., Gokulakrishnan, K., Prabu, P., Sathishkumar, C., Ranjani, H., & Mohan, V. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0727-3 · Cited by 237
“Studies performed in a variety of cell and animal based experimental systems suggest that NFjB activation is a key event early in the pathobiology of diabetes [30, 31].”
BackgroundTataranni, P. A., & Ortega, E. (2005) · Diabetes · doi:10.2337/diabetes.54.4.917 · Cited by 238
Missner, A., & Pohl, P. (2009) · ChemPhysChem · doi:10.1002/cphc.200900270 · Cited by 233
Inflammation and the etiology of type 2 diabetes
Sjöholm, Å., & Nyström, T. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.568 · Cited by 235
Insulin resistance and hyperinsulinaemia in the development and progression of cancer
Godsland, I. F. (2010) · Clinical Science · doi:10.1042/cs20090399 · Cited by 231
Modulation of the JNK Pathway in Liver Affects Insulin Resistance Status
Nakatani, Y., Kaneto, H., Kawamori, D., Hatazaki, M., Miyatsuka, T., Matsuoka, T.-A., Kajimoto, Y., Matsuhisa, M., Yamasaki, Y., & Hori, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406963200 · Cited by 232
Adipokines, inflammation, and the endothelium in diabetes
Aldhahi, W., & Hamdy, O. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0020-2 · Cited by 232
“Increased circulating cytokines and growth factors are strongly related to inflammation, which is currently viewed by many researchers as a possible key player in the etiology of atherosclerosis and diabetes [16, 17 ].”
Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia
Sparks, J. D., Sparks, C. E., & Adeli, K. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241463 · Cited by 231
Approach to the Pathogenesis and Treatment of Nonalcoholic Steatohepatitis
Medina, J., Fernández-Salazar, L. I., García-Buey, L., & Moreno-Otero, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2057 · Cited by 229
Nuclear receptors versus inflammation: mechanisms of transrepression
Pascual, G., & Glass, C. K. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.08.005 · Cited by 228
The Role of Cytokines in Non-Alcoholic Fatty Liver Disease
Tilg, H. (2010) · Digestive Diseases · doi:10.1159/000282083 · Cited by 227
AMP‐activated protein kinase: role in metabolism and therapeutic implications
Schimmack, G., DeFronzo, R. A., & Musi, N. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00561.x · Cited by 227
Kim, J. K., Gimeno, R. E., Higashimori, T., Kim, H.-J., Choi, H., Punreddy, S., Mozell, R. L., Tan, G., Stricker-Krongrad, A., Hirsch, D. J., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18917 · Cited by 226
How Metabolism Generates Signals during Innate Immunity and Inflammation
McGettrick, A. F., & O'Neill, L. A. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r113.486464 · Cited by 225
“(41) demonstrated that the treatment of obese mice with salicylate results in a significant decrease in blood glucose levels, whereas clinical trials with salsalate, a non-acetylated prodrug of salicylate, showed a reduction in blood glucose levels in patients with T2D (42).”
BackgroundManrique, C., Lastra, G., Gardner, M., & Sowers, J. R. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.02.014 · Cited by 224
“In addition, increases in inflammatory molecule NK-kB, a key mediator of inflammation, is triggered by activation of the Ser kinase IKK-b, a process that is reversed by salicylates.(57) In this context, treatment with high doses of aspirin results in increased insulin sensitivity, reduced hepatic glucose output, and i…”
BackgroundCurcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice
Leclercq, I. A., Farrell, G. C., Sempoux, C., Peña, A. D., & Horsmans, Y. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.010 · Cited by 224
“Increased serum TNF levels and hepatic TNF mRNA have been reported in humans with NASH [13–15], while increased TNF signalling has been implicated in obesity, steatosis and insulin resistance associated with nonalcoholic fatty liver diseases (NAFLD) [16–19].”
BackgroundWellen, K. E., Fucho, R., Gregor, M. F., Furuhashi, M., Morgan, C., Lindstad, T., Vaillancourt, E., Gorgun, C. Z., Saatcioglu, F., & Hotamisligil, G. S. (2007) · Cell · doi:10.1016/j.cell.2007.02.049 · Cited by 222
“Experiments with loss-of-function mouse models have demonstrated the central role of these inflammatory pathways in metabolic diseases (Uysal et al., 1997; Yuan et al., 2001; Hirosumi et al., 2002; Howard et al., 2004; Arkan et al., 2005; Cai et al., 2005).”
BackgroundA decade of progress in adipose tissue macrophage biology
Hill, A. A., Reid Bolus, W., & Hasty, A. H. (2014) · Immunological Reviews · doi:10.1111/imr.12216 · Cited by 222
“Dampening of the NF-jB pathway has been known for some time to improve systemic insulin sensitivity (93); however, AT-specific effects of NF-jB were not discovered until more recently.”
BackgroundEhses, J. A., Meier, D. T., Wueest, S., Rytka, J., Boller, S., Wielinga, P. Y., Schraenen, A., Lemaire, K., Debray, S., Van Lommel, L., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1747-3 · Cited by 222
“Indeed, clinical data have shown improved insulin resistance after treatment of type 2 diabetes patients with salicylate (via inhibition of nuclear factor κB [NF-κB]) [4, 5], and improved beta cell insulin secretion in patients after treatment with the IL-1 receptor antagonist (IL-1Ra) [6].”
BackgroundObesity-induced inflammatory changes in adipose tissue
Wellen, K. E., & Hotamisligil, G. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320514 · Cited by 1,823
“For example, exploring the contributions of TNF-α, adiponectin, JNK, and inhibitor of NF-κB kinase β (IKKβ) (2, 12, 13, 15) to adipose tissue inflammation in mice with null mutations in these genes might provide insights into the aspects of the inflammatory response that are relevant to insulin action.”
BackgroundWullaert, A., van Loo, G., Heyninck, K., & Beyaert, R. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0031 · Cited by 218
Kelley, G. L., Allan, G., & Azhar, S. (2004) · Endocrinology · doi:10.1210/en.2003-1167 · Cited by 216
The Immune System as a Sensor of the Metabolic State
Odegaard, J. I., & Chawla, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.001 · Cited by 216
Sinha, S., Perdomo, G., Brown, N. F., & O'Doherty, R. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406514200 · Cited by 215
Ascorbic Acid: Its Role in Immune System and Chronic Inflammation Diseases
Sorice, A., Guerriero, E., Capone, F., Colonna, G., Castello, G., & Costantini, S. (2014) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557514666140428112602 · Cited by 212
“Actually, it has been reported that several inflammatory molecules, such as TNF-α, IL-6, MCP-1 and iNOS (inducible NO synthase), correlate with increased body adiposity and inflammatory-related pathways are activated in obesity and insulin resistance states [79-81].”
BackgroundKim, J. K., Gimeno, R. E., Higashimori, T., Kim, H.-J., Choi, H., Punreddy, S., Mozell, R. L., Tan, G., Stricker-Krongrad, A., Hirsch, D. J., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200418917 · Cited by 212
Recent advances in obesity-induced inflammation and insulin resistance
Tateya, S., Kim, F., & Tamori, Y. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00093 · Cited by 211
“Given that IKKβ is a key downstream mediator of insulin resistance and its blockade by salicylates attenuated hyperglycemia, hyperinsulinemia, and dyslipidemia in obese rodents (130, 131), Hundal et al.”
BackgroundGehrke, N., & Schattenberg, J. M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.020 · Cited by 209
Non-alcoholic fatty liver disease: lumen–liver interactions and possible role for probiotics
Solga, S. F., & Diehl, A. M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00097-7 · Cited by 210
Fujimoto, M., Shimizu, N., Kunii, K., Martyn, J. A. J., Ueki, K., & Kaneki, M. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1340 · Cited by 209
Inflammatory cytokines in acute renal failure
Ramesh, G., & Reeves, W. B. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09109.x · Cited by 208
The Role of Inflammation in β-cell Dedifferentiation
Nordmann, T. M., Dror, E., Schulze, F., Traub, S., Berishvili, E., Barbieux, C., Böni-Schnetzler, M., & Donath, M. Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-06731-w · Cited by 204
Gandhi, G. R., Jothi, G., Antony, P. J., Balakrishna, K., Paulraj, M. G., Ignacimuthu, S., Stalin, A., & Al-Dhabi, N. A. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.044 · Cited by 204
Maternal Obesity, Inflammation, and Fetal Skeletal Muscle Development1
Du, M., Yan, X., Tong, J. F., Zhao, J., & Zhu, M. J. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.109.077099 · Cited by 204
López‐Candales, A., Burgos, P. M. H., Hernández-Suárez, D. F., & Harris, D. A. (2017) · PubMed · Cited by 252
Carter-Kent, C., Zein, N. N., & Feldstein, A. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01709.x · Cited by 203
Hypothalamic Inflammation in the Control of Metabolic Function
Valdearcos, M., Xu, A. W., & Koliwad, S. K. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071656 · Cited by 201
Zhu, M. J., Du, M., Nathanielsz, P. W., & Ford, S. P. (2010) · Placenta · doi:10.1016/j.placenta.2010.02.002 · Cited by 199
“Toll-like receptor (TLR) 4 is a major factor that drives the inflammatory NF-kB pathway [43]”
Mima, A. (2013) · Journal of Diabetes Research · doi:10.1155/2013/248563 · Cited by 198
McGillicuddy, F. C., Harford, K. A., Reynolds, C. M., Oliver, E., Claessens, M., Mills, K. H. G., & Roche, H. M. (2011) · Diabetes · doi:10.2337/db10-1278 · Cited by 199
“Furthermore, TNF-a, TLR4, and IL-1 signaling pathways converge at the inhibitor of NFkB kinase (IKK)/NFkB axis (25), with marked protection of IKK mice against IR (26,27).”
BackgroundXiao, C., Giacca, A., & Lewis, G. F. (2011) · Diabetes · doi:10.2337/db10-1433 · Cited by 197
Martín-Vázquez, E., Cobo-Vuilleumier, N., López-Noriega, L., Lorenzo, P. I., & Gauthier, B. R. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.86492 · Cited by 192
Jiao, P., Ma, J., Feng, B., Zhang, H., Alan‐Diehl, J., Eugene‐Chin, Y., Yan, W., & Xu, H. (2011) · Obesity · doi:10.1038/oby.2010.200 · Cited by 198
“Heterozygous IKKβ knockout mice are protected from developing insulin resistance induced by HFD and leptin deficiency (35).”
BackgroundRoles of NF-κB in health and disease: mechanisms and therapeutic potential
Wong, E. T., & Tergaonkar, V. (2009) · Clinical Science · doi:10.1042/cs20080502 · Cited by 196
Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-α
Ramesh, G., & Reeves, W. B. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00413.x · Cited by 196
“However, high doses of salicylates also inhibit the activity of IκB kinase β (IKK), thereby reducing nuclear factor kappa B (NF-κB) transcriptional activit”
BackgroundResistin- and Obesity-associated Metabolic Diseases
Lazar, M. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-985897 · Cited by 195
“The interaction between infl ammation and insulin signaling is also suggested by the ability of aspirin to improve insulin resistance, in part by preventing the antagonistic effects of fatty acids and cytokines [35] .”
Gualillo, O., González-Juanatey, J. R., & Lago, F. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.09.005 · Cited by 193
“Salicylate derivatives, classical antiinflammatory drugs that modulate the nuclear factor κB pathway, have been proven to prevent obesity and diet-induced insulin resistance (Yuan et al. 2001).”
BackgroundHan, J. M., Wu, D., Denroche, H. C., Yao, Y., Verchere, C. B., & Levings, M. K. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500020 · Cited by 193
Pathogenesis of Non-alcoholic Steatohepatitis: Human Data
Edmison, J., & McCullough, A. J. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.011 · Cited by 193
Gao, S., McMillan, R. P., Zhu, Q., Lopaschuk, G. D., Hulver, M. W., & Butler, A. A. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.01.005 · Cited by 192
“The JNK/IKK kinases inhibit insulin-induced tyrosine phosphorylation of insulin receptor substrates (IRS) [68].”
BackgroundInfluentialRobblee, M. M., Kim, C. C., Abate, J. P., Valdearcos, M., Sandlund, K. L. M., Shenoy, M. K., Volmer, R., Iwawaki, T., & Koliwad, S. K. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.053 · Cited by 192
“Cell (Yuan et al., 2001; Solinas et al., 2007).”
Pathogenic perspectives for the role of inflammation in diabetic nephropathy
Rivero, A., Mora, C., Muros, M., García, J., Herrera, H., & Navarro-González, J. F. (2009) · Clinical Science · doi:10.1042/cs20080394 · Cited by 190
Metabolic inflammation: Connecting obesity and insulin resistance
Dali-Youcef, N., Mecili, M., Ricci, R., & Andrès, E. (2013) · Annals of Medicine · doi:10.3109/07853890.2012.705015 · Cited by 190
Targeting inflammation in diabetes: Newer therapeutic options
Agrawal, N. K. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i5.697 · Cited by 186
Bioactive lipids in metabolic syndrome
Nagao, K., & Yanagita, T. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.12.002 · Cited by 185
Ruan, H., Pownall, H. J., & Lodish, H. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303141200 · Cited by 185
Connecting Type 1 and Type 2 Diabetes through Innate Immunity
Odegaard, J. I., & Chawla, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007724 · Cited by 186
“Similarly, cytokines and adipokines activate multiple suppressor of cytokine signaling (SOCS) proteins (notably SOCS3), which interfere with activating tyrosine phosphorylation of IRS-1 and IRS-2 and target them for proteasomal degradation (Qatanani and Lazar 2007).”
BackgroundInfluentialNon‐alcoholic steatohepatitis: Definitions and pathogenesis
DAY, C., & SAKSENA, S. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s3.31.x · Cited by 185
Activation of the Transcriptional Function of the NF-κB Protein c-Rel by O -GlcNAc Glycosylation
Ramakrishnan, P., Clark, P. M., Mason, D. E., Peters, E. C., Hsieh-Wilson, L. C., & Baltimore, D. (2013) · Science Signaling · doi:10.1126/scisignal.2004097 · Cited by 184
Fujishiro, M., Gotoh, Y., Katagiri, H., Sakoda, H., Ogihara, T., Anai, M., Onishi, Y., Ono, H., Abe, M., Shojima, N., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0131 · Cited by 184
Li, Q., Pène, V., Krishnamurthy, S., Cha, H., & Liang, T. J. (2013) · Nature Medicine · doi:10.1038/nm.3190 · Cited by 183
Inflammation and diabetic nephropathy
Mora, C., & Navarro, J. F. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0080-1 · Cited by 183
“Salicylates reversed insulin resistance in genetically obese fa/fa rats and ob/ob mice via an IκB kinase β-dependent mechanism [ 13 ].”
Backgroundde Mello, V. D. F., Lankinen, M., Schwab, U., Kolehmainen, M., Lehto, S., Seppänen-Laakso, T., Orešič, M., Pulkkinen, L., Uusitupa, M., & Erkkilä, A. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1482-9 · Cited by 181
“Moreover, a role for NFκB and IKKβ in the development of IR and type 2 diabetes has been described and has been linked to inflammation [13].”
Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications
Xie, S., Xu, S.-C., Deng, W., & Tang, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01378-8 · Cited by 177
“Consequently, insulin resistance is accelerated, and cellular senescence is further promoted.(70,71) These lines of evidence indicate that abnormal cardiac lipid metabolism promotes cardiac aging (Fig.”
BackgroundPigment Epithelium-Derived Factor Contributes to Insulin Resistance in Obesity
Crowe, S., Wu, L. E., Economou, C., Turpin, S. M., Matzaris, M., Hoehn, K. L., Hevener, A. L., James, D. E., Duh, E. J., & Watt, M. J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.06.001 · Cited by 180
“The importance of both JNK and IKK to the etiology of insulin resistance is highlighted by the consistent observations that the global (Hirosumi et al., 2002; Yuan et al., 2001) or tissue-specific deletion of these stress kinases markedly improves insulin sensitivity and glucose homeostasis in genetically obese (ob/ob…”
BackgroundBadawi (2010) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmsott.s9089 · Cited by 177
“Indeed, heterozygous deletion in IKKβ (ie, in IKKβ+/- mice) improved insulin sensitivity in obese mice target cells.(57) In addition, TNF-α upregulates the expression of suppressor of cytokine signaling (SOCS) proteins, which bind to IRS-1 to mediate its degradation.”
BackgroundMatsumoto, M., Ogawa, W., Akimoto, K., Inoue, H., Miyake, K., Furukawa, K., Hayashi, Y., Iguchi, H., Matsuki, Y., Hiramatsu, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18816 · Cited by 178
“The Journal of Clinical Investigation | September 2003 | Volume 112 | Number 6 943 sitivity both in rodent models of diabetes and in human subjects (43, 44).”
BackgroundMetabolic impact of estrogen signalling through ERalpha and ERbeta
Foryst-Ludwig, A., & Kintscher, U. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.06.012 · Cited by 178
Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes
Blaschke, F., Takata, Y., Caglayan, E., Law, R. E., & Hsueh, W. A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191663.12164.77 · Cited by 176
Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease
Choudhury, J., & Sanyal, A. J. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.006 · Cited by 177
“TNF-a not only increases ROS formation but also has a variety of effects on key intracellular processes including activation of the key transcriptional regulator NF-kb [88].”
BackgroundChang, Y., & Chuang, L. (2010) · PubMed Central · Cited by 253
Animal models of steatohepatitis
Koteish, A., & Mae Diehl, A. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0332 · Cited by 175
Intestinal Microbiota During Infancy and Its Implications for Obesity
Reinhardt, C., Reigstad, C. S., & Bäckhed, F. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318183187c · Cited by 175
Inflammation during obesity is not all bad: evidence from animal and human studies
Ye, J., & McGuinness, O. P. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00266.2012 · Cited by 174
Nonalcoholic steatohepatitis: what we know in the new millennium1
Harrison, S. A., Kadakia, S., Lang, K. A., & Schenker, S. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.07069.x · Cited by 173
Inflammation and NF-κB in Alzheimer's Disease and Diabetes
Granic, I., Dolga, A. M., Nijholt, I. M., van Dijk, G., & Eisel, U. L. M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0976 · Cited by 173
“Several reports have shown that IKKβ, which is responsible for the activation of NF-κB, was also increased in insulin-resistant cells [49,51].”
CXCL16 Is a Marker of Inflammation, Atherosclerosis, and Acute Coronary Syndromes in Humans
Lehrke, M., Millington, S. C., Lefterova, M., Cumaranatunge, R. G., Szapary, P., Wilensky, R., Rader, D. J., Lazar, M. A., & Reilly, M. P. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.034 · Cited by 173
“In vitro, aspirin blocked LPS induction of CXCL16 mRNA (Fig. 2A) and protein (Fig. 2B) in human macrophages at concentrations (5 mM) that inhibit I-kappa-B kinase ( 21 ).”
BackgroundYu, Z., Shao, W., Chiang, Y., Foltz, W., Zhang, Z., Ling, W., Fantus, I. G., & Jin, T. (2011) · Diabetologia · doi:10.1007/s00125-010-2001-8 · Cited by 173
“Several signalling abnormalities caused by alteration of redox homeostasis may also indirectly impair insulin signalling [10], as exemplified by inflammatory signalling and endoplasmic reticulum (ER) stress [11, 12].”
BackgroundJové, M., Planavila, A., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez-Carrera, M. (2006) · Endocrinology · doi:10.1210/en.2005-0440 · Cited by 172
Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
Goldfine, A. B., & Shoelson, S. E. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88884 · Cited by 172
Self-citationYe, J., & Keller, J. N. (2010) · Aging · doi:10.18632/aging.100155 · Cited by 170
“Activation of inflammatory kinases such as IKKβ (IkBα kinase beta) and JNK1 (c-Jun N-terminal kinase 1) provides additional evidence for activation of intracellular inflammatory pathways in obesity [5-6].”
BackgroundInsulin Resistance and Cancer: In Search for a Causal Link
Chiefari, E., Mirabelli, M., La Vignera, S., Tanyolaç, S., Foti, D. P., Aversa, A., & Brunetti, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011137 · Cited by 170
“In addition, high FFA levels can amplify the proinflammatory response via NFκB signaling and increased secretion of pro-inflammatory cytokines such as IL-6, IL-1, TNF-α, and MCP-1 [185].”
BackgroundInfluentialHasegawa, Y., Saito, T., Ogihara, T., Ishigaki, Y., Yamada, T., Imai, J., Uno, K., Gao, J., Kaneko, K., Shimosawa, T., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.054346 · Cited by 169
Dasgupta, S., Bhattacharya, S., Biswas, A., Majumdar, S. S., Mukhopadhyay, S., Ray, S., & Bhattacharya, S. (2010) · Biochemical Journal · doi:10.1042/bj20100330 · Cited by 168
Pancreatic β-cell growth and survival – a role in obesity-linked type 2 diabetes?
Lingohr, M. K., Buettner, R., & Rhodes, C. J. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02377-8 · Cited by 168
Central Adiposity, Systemic Inflammation, and the Metabolic Syndrome
Elks, C. M., & Francis, J. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0096-4 · Cited by 166
Lipids and Glucose in Type 2 Diabetes
Boden, G., & Laakso, M. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2253 · Cited by 167
“NF- B has been linked to fatty acid– induced impairment of insulin action in rodents (23,24).”
BackgroundReactive species and early manifestation of insulin resistance in type 2 diabetes
Fridlyand, L. E., & Philipson, L. H. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00496.x · Cited by 166
Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes
Jiao, P., Chen, Q., Shah, S., Du, J., Tao, B., Tzameli, I., Yan, W., & Xu, H. (2009) · Diabetes · doi:10.2337/db07-1344 · Cited by 166
“The IKK /NF- B axis has been demonstrated to be the molecular target for the hypoglycemic actions of salicylates (33,34).”
BackgroundTang, X., Guilherme, A., Chakladar, A., Powelka, A. M., Konda, S., Virbasius, J. V., Nicoloro, S. M. C., Straubhaar, J., & Czech, M. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507660103 · Cited by 164
Pathophysiology of NASH: perspectives for a targeted treatment
Marra, F., & Lotersztajn, S. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990344 · Cited by 163
“Marra & Lotersztajn, 12 critically contributes to insulin resistance [59].”
White, M. F. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-008 · Cited by 163
Federici, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26052 · Cited by 163
“Although clinical trials with angiotensin-converting enzyme inhibitors and salicylates suggest that the reduction of inflammation can help to maintain glucose homeostasis (29, 30), the molecular mechanisms explaining how control of inflammation influences both type 2 diabetes and atherosclerosis are only partially kno…”
Neurodegeneration in an animal model of Parkinson’s disease is exacerbated by a high-fat diet
Morris, J. K., Bomhoff, G. L., Stanford, J. A., & Geiger, P. C. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00449.2010 · Cited by 163
Role of NF-κB in Ageing and Age-Related Diseases: Lessons from Genetically Modified Mouse Models
García-García, V. A., Alameda, J. P., Page, A., & Casanova, M. L. (2021) · Cells · doi:10.3390/cells10081906 · Cited by 161
“Studies using Ikkβ+/− mice [147] or conditional transgenic mice of Ikkβ specifically in the liver [148,149] (Table 4), showed that deficiency of IKKβ protected against the development of insulin resistance during high-fat feeding.”
BackgroundAdipocyte differentiation induces dynamic changes in NF-κB expression and activity
Berg, A. H., Lin, Y., Lisanti, M. P., & Scherer, P. E. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00002.2004 · Cited by 162
“Inhibition of the inflammatory signaling complex IKK , which acts through the transcription factor NF- B, improves the insulin resistance and dyslipidemia associated with obesity (22, 28, 36, 51).”
BackgroundMechanisms of obesity and related pathology: linking immune responses to metabolic stress
Karalis, K. P., Giannogonas, P., Kodela, E., Koutmani, Y., Zoumakis, M., & Teli, T. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07304.x · Cited by 160
Wang, X.-A., Zhang, R., She, Z.-G., Zhang, X.-F., Jiang, D.-S., Wang, T., Gao, L., Deng, W., Zhang, S.-M., Zhu, L.-H., et al. (2014) · Hepatology · doi:10.1002/hep.26751 · Cited by 159
“Mice heterozygous for IKKb are also protected from obesity-induced insulin resistance.(30) The importance of IKKb/NF-jB in regulating metabolism is particularly true for the liver.”
BackgroundBradley, R. L., Fisher, F. M., & Maratos‐Flier, E. (2008) · Obesity · doi:10.1038/oby.2008.39 · Cited by 160
“signaling via the TNF-α inducible IKKβ/NF-κB pathway, a key signaling pathway in tissue inflammation, through the use of salicylate-based inhibitors or by decreased IKKβ expression improved insulin sensitivity in vivo (24,25).”
Background
Metadata
- Authors
- Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E.
- Affiliations
- Joslin Diabetes Center (US)
- Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093, USA.
- University of California San Diego (US)
- Corresponding author
- Yuan, Minsheng
- Konstantopoulos, Nicky
- Lee, Jongsoon
- Shoelson, Steven E.
- Venue
- Science
- Published
- 2001-08-31
- Volume
- 293
- Issue
- 5535
- Pages
- 1673-1677
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2031637294
- Cited by
- 1,884
- References
- 26
- Citations by year
- 2026: 16 · 2025: 29 · 2024: 27 · 2023: 36 · 2022: 41 · 2021: 51 · 2020: 51 · 2019: 61 · 2018: 54 · 2017: 70 · 2016: 78 · 2015: 93 · 2014: 109 · 2013: 124 · 2012: 99
- FWCI
- 56.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29dk045493-05)
- National Institute of Allergy and Infectious Diseases (AI 43477)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 51729, DK45493)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- insulin resistance, obesity, salicylates, IκB kinase β, insulin signaling, inflammation, type 2 diabetes, hyperinsulinemia, hyperglycemia, dyslipidemia, high-fat diet, ob/ob mice, insulin sensitization, cyclooxygenase
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Blood Glucose, Cell Line, Dietary Fats, Glucose Tolerance Test, Insulin, Insulin Resistance, Lipids, Liver, Male, Mice, Obese, Muscles, Obesity, Phosphorylation, Prostaglandin-Endoperoxide Synthases, Rats, Zucker, Receptor, Insulin, Sodium Salicylate, Tumor Necrosis Factor-alpha, Signal Transduction, Protein Serine-Threonine Kinases, Gene Deletion, Gene Targeting, Mice, Rats, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.